A molecular pathway could explain how a class of drugs leads to heart failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Nissen, S. E. & Wolski, K. N. Engl. J. Med. 356, 2457–2471 (2007).
Krishnan, J. et al. Cell Metab. 9, 512–524 (2009).
Home, P. D. et al. Lancet 373, 2125 - 2135 (2009).
Related links
Rights and permissions
About this article
Cite this article
Schubert, C. Heart study questions diabetes drugs. Nature (2009). https://doi.org/10.1038/news.2009.588
Published:
DOI: https://doi.org/10.1038/news.2009.588